Top AI in Endoscopy Companies Revolutionizing Real-Time Diagnostics and Intelligent Endoscopic Care

The journey of endoscopy began when physicians first attempted to observe internal organs using simple optical instruments. Early endoscopes used basic light sources and mirrors to provide limited visual access inside the human body. Over time, medical engineers improved these instruments through better illumination systems, flexible tubes, and miniature cameras. These improvements allowed doctors to examine internal structures with greater clarity while reducing the need for invasive surgical procedures.

The introduction of AI has added a new dimension to modern endoscopic procedures. Advanced algorithms are now being developed to analyze visual data produced during examinations. These systems can observe patterns, highlight abnormal tissue structures, and assist medical professionals during diagnostic procedures. AI tools are designed to work alongside physicians, supporting clinical decision making through real-time image analysis.

Recent innovations focus on deep learning models, computer vision technology, and real-time diagnostic assistance integrated directly into endoscopic platforms. These technological developments reflect the continuing evolution of endoscopy, where AI supports more precise observation, improved diagnostic accuracy, and enhanced medical care in modern healthcare environments.

Fortune Business Insights reports that the market for AI in endoscopy will account for USD 2.35 billion in 2026 and with a substantial CAGR of 25.92% reach USD 14.86 billion by 2034.

List of Top 10 AI in Endoscopy Brands Reported by Fortune Business Insights:

1. Medtronic

Medtronic advances AI within gastrointestinal endoscopy through the GI Genius intelligent endoscopy module. Headquartered in the U.S., Medtronic integrates real-time polyp detection algorithms achieving higher sensitivity for diminutive adenomas during colonoscopy procedures systematically. Computer-aided diagnosis classifies lesions instantly guiding biopsy decisions, while reducing unnecessary polypectomies substantially. The FDA-cleared module overlays color-coded markers upon suspicious mucosa enhancing adenoma detection rates throughout screening programs comprehensively. In November 2024, the company was awarded a 3-year contract from the U.S. Department of Veterans Affair for its GI Genius AI-based endoscopy units. Additionally, in April 2024, the firm also launched ColonPRO, a next-gen AI software for GI Genius intelligent endoscopy system.

2. Olympus Corporation

Olympus Corporation delivers ENDO-AID CADe computer-aided detection within the EVIS X1 endoscopy universe. Headquartered in Japan, the company employs deep learning algorithms scanning colon mucosa continuously identifying flat and sessile polyps overlooked during conventional white light examination routinely. Real-time alerts display detection confidence scores alongside lesion size estimation supporting standardized documentation protocols efficiently. Clinical trials confirm ENDO-AID elevates ADR from 48% to 67% across diverse patient populations systematically. In September 2024, the company received a FDA 510(k) clearance for its CADDIE, a first cloud-based AI endoscopy system for colonoscopy.

3. FUJIFILM Holdings Corporation

FUJIFILM Holdings Corporation pioneers in CAD-EYE real-time polyp detection within ELUXEO endoscopy platform. Headquartered in Japan, FUJIFILM integrates convolutional neural networks analyzing magnified NBI images identifying neoplastic polyps with higher accuracy during withdrawal phases precisely. Augmented reality overlays highlight lesion boundaries while automated polyp measurement streamlines reporting requirements efficiently. Multi-center studies validate CAD-EYE increases polyp detection by higher conventional colonoscopy performance. In March 2024, the company received U.S. FDA 510 (k) clearance for its CAD-EYE platform.

4. PENTAX Medical

PENTAX Medical develops DISCOVERY AI real-time polyp detection integrated within i10 series colonoscopes. Headquartered in Japan, the company offers hybrid AI architecture combining lesion localization with optical biopsy characterization analyzing TEXTURE AND VESSEL patterns simultaneously. EndoBRAIN-EYE classifies Paris classification lesions instantly while EndoBRAIN-ANALYTICS quantifies bowel preparation quality. Japanese multicenter trials demonstrate that DISCOVERY elevates adenoma detection serving national screening programs effectively. In February 2026, the company was present at Connect Labs by Wexford for advancing clinical education. It also announced a partnership with IRCAD Africa in April 2025, to advance flexible endoscopy training in Rwanda.

5. Iterative Health

Iterative Health, headquartered in the U.S., delivers SKOUT polyp detection platform revolutionizing AI endoscopy outcomes measurably. The company's cloud-connected algorithms analyze full video streams detecting polyps across multiple clinical sites achieving more sensitivity for lesions smaller than 5mm precisely. SKOUT ATLAS generates personalized endoscopist feedback improving individual performance continuously while SKOUT INSIGHT benchmarks organizational ADR against national quality metrics systematically. This SKOUT system was approved with a clearance letter from the U.S. FDA in May 2025.

6. AI Medical Service Inc.

Al Medical Service Inc., headquartered in Japan, engineers EndoBRAIN Video Atlas characterizing colorectal lesions through computer-aided diagnosis. The firm combines CAD-EYE detection with EndoBRAIN characterization predicting deep submucosal invasion risk analyzing microvascular patterns quantitatively. J-SON multicenter study validates higher accuracy differentiating high-risk adenomas from hyperplastic polyps supporting "resect-and-discard" protocols safely. Cloud-based training modules enhance endoscopist diagnostic confidence systematically.

7. Wision A.I.

Wision A.I. develops EndoAngel real-time quality monitoring platform optimizing colonoscopy performance objectively. Headquartered in China, the company employs multimodal AI assessing bowel preparation adequacy, withdrawal time compliance, and polyp localization simultaneously through panoramic video analysis continuously. Automated bowel prep scoring correlates strongly with Boston Bowel Preparation Scale while withdrawal monitors enforce minimum inspection duration precisely. Chinese GI centers implement EndoAngel standardizing quality metrics nationwide consistently.

8. Body Vision Medical

Body Vision Medical pioneers LungVision AI-powered bronchoscopic navigation transforming pulmonary endoscopy precision dramatically. Headquartered in the U.S., its electromagnetic navigation integrates real-time 3D CT reconstruction guiding biopsy needles toward peripheral nodules continuously. LungVision Planner generates patient-specific digital twins while navigation software overlays virtual bronchoscopy upon live endoscopic video seamlessly. Clinical adoption demonstrates high diagnostic yield improvement serving early-stage lung cancer detection programs effectively.

9. Endovision

Endovision, headquartered in India, develops EndoAI capsule endoscopy analysis platform serving resource-constrained healthcare systems efficiently. The company employs lightweight AI models detecting small bowel ulcers, erosions, and angiodysplasias within wireless capsule footage rapidly. Cloud-based processing generates lesion heatmaps alongside severity scoring supporting remote gastroenterologist review workflows comprehensively. Indian multicenter validation confirms higher sensitivity matching expert radiologists while accelerating diagnosis turnaround serving national IBD registries systematically.

10. MAGENTIQ EYE

MAGENTIQ EYE delivers MAGENTIQ-COLO polyp detection system achieving highest published sensitivity rates globally. Headquartered in Israel, the firm's deep learning architecture analyzes colonoscopic video continuously identifying overlooked polyps within folds and behind haustral folds precisely. Real-time bounding boxes quantify detection confidence while automated lesion flagging streamlines pathology correlation workflows efficiently. International multicenter trials validate an increase in detecting challenging polyp morphologies serving quality improvement initiatives worldwide consistently.

Advancements in Cloud-Based Data System Will Reshape the Future of AI in Endoscopy Industry

Future endoscopic platforms may integrate cloud-based data systems that allow secure storage and collaborative analysis of medical images. Such platforms may support medical professionals in reviewing clinical findings, sharing diagnostic insights, and improving treatment planning across healthcare institutions. As healthcare technology continues to advance, AI will likely remain an important partner in endoscopic practice. Its future development reflects a path shaped by intelligent imaging systems, improved diagnostic accuracy, and digital innovation designed to support safer and more effective medical care for patients worldwide.